Effect of Multispecies Probiotic Supplementation on the Efficacy of Rifaximin α Therapy in Patients With Small Intestinal Bacterial Overgrowth (SIBO): a Randomized Placebo-controlled Trial

Clinical trial NCT07426705 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07426705
Sponsor: Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Small Intestinal Bacterial Overgrowth Syndrome (SIBO)IBS

Start date: 2026-02-15
Primary completion: 2027-07-15
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.